IMARC Group, a leading market research company, has recently releases report titled “Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global immunohematology market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the immunohematology market?
Report Attributes
Details
Market Size in 2022
US$ 1.9 Billion
Market Forecast in 2028
US$ 2.5 Billion
Growth rate (2023 to 2028)
CAGR of 4.7%
Base Year of the Analysis
2022
Forecast Period
2023-2028
What is immunohematology?
Immunohematology refers to a branch of medical sciences that studies the reactions between blood antigens, antibodies and blood proteins in relation to immune response. It is essential in blood banking, wherein it is used to prepare blood components for transfusion and reducing transfusion-related fatalities, like HIV and thalassemia. Immunohematology also forms a critical element of the development of transfusion medicine.
Request for a free sample copy of this report: https://www.imarcgroup.com/immunohematology-market/requestsample
What are the growth prospects and trends in the immunohematology industry?
The global immunohematology market is primarily driven by the growing instances of hematological disorders around the globe. The market growth is further supported by public and private investments to increase the number of blood banks and awareness programs regarding blood donation and screening. Furthermore, improvements in healthcare infrastructure and the development of next-generation immunohematology devices have enhanced the efficacy of the diagnosis and minimized analysis time and the risk of human errors. Moreover, the development of innovative transfusion systems and fully automated instruments are expected to create a positive outlook for the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Analyzing Systems
- Reagents and Consumables
Breakup by Technology:
- Biochips
- Gel Cards
- Microplates
- Polymerase Chain Reaction
- Erythrocyte-Magnetized Technology (EMT)
- Others
Breakup by Application:
- Blood-Related Diseases
- HIV
- Hepatitis
- Blood Transfusion
- Others
Breakup by End-User:
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott
- Antisel
- BD (Becton Dickinson and Company)
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Grifols S.A.
- Merck KGaA
- MTC Invitro Diagnostics AG
- Ortho-Clinical Diagnostics Inc (The Carlyle Group)
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2256&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/